Skip to content

SANASPE

Active
Private limited companyfounded 200521 yrs activeWilstraat 1, 1070 Anderlecht, BelgiumKBO/BCE: BE 0874.832.607

The computed 12-month bankruptcy probability of SANASPE is 1.5% (moderate). The 2025 annual accounts show equity of €41k and a net result of €12k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 32% of 18039 sector peers (fiscal year 2025). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
65 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability72▼-10
Solvency38▲+2
Growth35▼-17
Track record100
Bankruptcy probability, 12 months
1.5% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €2.5k at 30 days acceptable
Liquidity ample (current ratio 1.7 against 1.3 in 2024; short-term debt: 15.7% of total assets), but 86.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 21 years 0 30 y
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
192122232425
2019 to 2025 · latest year €41k
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 03-02-2026, 3 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
3 d late
2024
199 d late
2023
55 d late
2022
36 d late
2021
23 d late
2020
18 d early
2019
46 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close17-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Turnover
€63k▼ 35.9%
2024 · €98k
2024: €98k
2024 → 2025
EBIT margin
34.4%▲ 11.8pp
2024 · 22.5%
2024: 22.5%
2024 → 2025
Net result
€12k▼ 6.9%
2024 · €13k
2019: €28k 2021: €87k 2022: €-13k 2023: €9k 2024: €13k
2019 → 2025
Working capital
€33k▲ 128%
2024 · €15k
2019: €-296k 2021: €-242k 2022: €-57k 2023: €-55k 2024: €15k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€98k€63k▼ 35.9%
Equity€-94k-€9k€18k▲ 99.0%€31k▲ 74.7%€41k▲ 30.2%
Operating result€129k-€15k▼ 88.4%€23k▲ 51.9%€22k▼ 2.2%€22k▼ 2.3%
Net result€87k-€-13k€9k€13k▲ 50.1%€12k▼ 6.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-50k€0€50k€100k€150kOperating result 2021: €129k€129kNet result 2021: €87k€87kOperating result 2022: €15k€15kNet result 2022: €-13k€-13kOperating result 2023: €23k€23kNet result 2023: €9k€9kOperating result 2024: €22k€22kNet result 2024: €13k€13kOperating result 2025: €22k€22kNet result 2025: €12k€12k20212022202320242025
The operating result has fallen two years in a row; 2025 is 2% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €306k
Fixed assets €224k▼ 4.0%
Current assets €82k▲ 28.5%
Equity and liabilities €306k
Equity €41k▲ 30.2%
Provisions €53k=
Debt €212k▼ 0.3%
The debt ratio falls from 71.5% to 69.2%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€32k
2024 · €32k
Cash flow
€22k
2024 · €23k
Solvency
13.3%
2024 · 10.5%
Current ratio
1.70
2024 · 1.30
Quick ratio
1.70
2024 · 1.30
Debt / equity
5.19
2024 · 6.78
ROE
30.6%
2024 · 42.7%
ROA
4.1%
2024 · 4.5%
Interest coverage
4.13
2024 · 5.88
Debt
€212k
2024 · €212k
Debt ≤ 1 year
€48k
2024 · €49k
Debt > 1 year
€163k=
2024 · €163k
Income taxes
€2k
2024 · €3k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€297k€306k
Fixed assets21/28€233k€224k
Tangible fixed assets22/27€233k€224k
Land and buildings22€233k€223k
Plant, machinery and equipment23-€206
Furniture and vehicles24-€454
Current assets29/58€63k€82k
Amounts receivable within one year40/41€63k€82k
Trade receivables40€57k€72k
Other amounts receivable41€6k€10k
Equity and liabilities
Total equity and liabilities10/49€297k€306k
Equity10/15€31k€41k
Contributions10/11€128k€128k=
Revaluation surpluses12€85k€85k=
Reserves13€22k€22k=
Tax-exempt reserves132€22k€22k=
Profit (loss) carried forward14€-204k€-195k
Provisions and deferred taxes16€53k€53k=
Provisions for liabilities and charges160/5€46k€46k=
Environmental obligations163€30k€30k=
Other liabilities and charges164/5€16k€16k=
Deferred taxes168€7k€7k=
Amounts payable17/49€212k€212k
Amounts payable after more than one year17€163k€163k=
Financial debts170/4€163k€163k=
Other amounts payable178/9€100€100=
Amounts payable within one year42/48€49k€48k
Current portion of amounts payable after more than one year42€14k€10k
Trade debts44€10k€16k
Suppliers440/4€10k€16k
Taxes, remuneration and social security45€14k€18k
Taxes450/3€14k€18k
Other amounts payable47/48€11k€5k
Accrued charges and deferred income492/3€790€790=
Income statement Code20242025
Turnover70€98k€63k
Goods, raw materials, services and sundry goods60/61€24k€26k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€10k
Provisions for liabilities and charges: additions (uses and reversals)635/8€46k-
Other operating charges640/8€3k€7k
Gross operating margin9900€81k€39k
Operating profit (loss)9901€22k€22k
Financial charges65/66B€5k€8k
Recurring financial charges65€5k€8k
Profit (loss) for the period before taxes9903€17k€14k
Income taxes67/77€3k€2k
Profit (loss) for the period9904€13k€12k
Transfer to tax-exempt reserves689-€3k
Profit (loss) for the period to be appropriated9905€13k€9k
Appropriation of the result
Profit (loss) to be appropriated9906€-204k€-195k
Profit (loss) brought forward from the previous period14P€-218k€-204k

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
03-02
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 3 days late
2025
18-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 199 days late
2024
30-06
Financial Liquidity times 13current ratio 1.30
Current ratio from 0.10 to 1.30; short-term debt falls from €61k to €49k.
26-03
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 55 days late
2023
30-06
Financial Back to profitnet €9k
Net result €9k after one loss-making year.
08-03
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 36 days late
2022
30-06
Financial Weakest financial yearnet €-13k ▼115%
Net result drops to €-13k, the lowest in the series; recovery starts the following year.
23-02
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 23 days late
2021
30-06
Financial Highest result since 2019net €87k ▲205%
Operating result €129k, net result €87k, both a record.
13-01
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2019
16-12
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
08-01
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
07-02
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 7 days late
2017
31-01
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 2 establishment units since 1966
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Wilstraat 11070 Anderlecht
Ground area
347 m²
Building footprint
141 m²
Volume, LiDAR
1,157 m³
2 parcels, Brussels · tallest building 16.8 m, ±4 floors. Linked by address, not a title deed.
2 establishment units
Espérance Pharma
Bergense Steenweg 1013, 1070 AnderlechtRetail sale of pharmaceutical products
since 19662.000.436.839
Espérance Pharma
Wilstraat 1, 1070 AnderlechtWarehousing and support activities for transportation
since 20062.152.102.376
2 parcels
Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21306D0126/00Y000 Brussels 268 m² 1 · 74 m² 10.4 m · 2 fl.
21308H0665/00M006 Brussels 79 m² 1 · 67 m² 16.8 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Anderlecht2.000.436.839
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Similar companies · same sector, comparable size

Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 2,458 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded04-07-2005
Fiscal year end30-06
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.